SGMOQ 8-K 2026-08-13

SANGAMO THERAPEUTICS, INC (SGMOQ) 8-K dated 2026-08-13 — accession 0001193125-26-347524.

SANGAMO THERAPEUTICS, INC (SGMOQ) common stock.

SANGAMO THERAPEUTICS, INC filed a 8-K on 2026-08-13. Accession 0001193125-26-347524.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SGMOQ revenue for 2025-12-31 was $39.6M. Net income was -$122.9M. Revenue was down 31.6% from 2024-12-31 to 2025-12-31.

Not investment advice. The SGMOQ SEC hub lists recent forms. The stock page is the research view.